FORWARD PHARMA A/S

Forward Pharma A/S (the "Company") is a limited liability company incorporated and domiciled in Denmark. The Company’s registered office is located in Hellerup, Denmark. The Company’s directly owned subsidiaries include Forward Pharma Operations ApS (“Operations”) and Forward Pharma USA, LLC (liquidated in June 2024). Operations’ has one directly owned subsidiary; Forward Pharma GmbH (“FP GmbH”). Operations and FP GmbH are both under voluntary liquidation. Similar, the Company is under voluntary liquidation. The Company and its directly and indirectly owned subsidiaries are referred to herein as the “Group.” Mutual Agreement Procedure The Danish and German tax authorities conducted a joint income tax audit of the Group’s Danish and German income tax returns for multiple years, up to and i…

The income statement of the Company for 2024 shows a profit of DKK 75,927,645, and at 31 December 2024 the balance sheet of the Company shows a positive equity of DKK 488,330,233. This year's result is positively influenced by the conclusion of the MAP and the development of the Company's bond portfolio.

Subsequent to 31 December 2024, there were no events that are required to be reported except for the above mentioned.

Other contingent liabilities

The Company is part of a Danish joint tax group. Under Danish tax rules, the Company is jointly and severally liable, with other members of the Danish tax group, for the tax obligations of the Danish tax group. Any adjustment to the Danish tax group’s taxable income could increase the Company’s liability.